NCT03079284

Brief Summary

Ten infants undergoing therapeutic hypothermia for hypoxic-ischemic encephalopathy will be enrolled in a new protocol that will allow mothers to hold their infants during the hypothermia treatment period. This is a safety study that will assess whether or not there is an increase in adverse event frequency in infants that are held during hypothermia. Parents and NICU nurses will be given a questionnaire after holding is complete investigating their feelings on maternal-infant bonding and safety of the holding protocol.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 6, 2017

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 14, 2017

Completed
6 days until next milestone

Study Start

First participant enrolled

March 20, 2017

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 23, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 23, 2017

Completed
4.3 years until next milestone

Results Posted

Study results publicly available

January 26, 2022

Completed
Last Updated

September 4, 2025

Status Verified

August 1, 2025

Enrollment Period

6 months

First QC Date

March 6, 2017

Results QC Date

May 29, 2019

Last Update Submit

August 22, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Frequency of Adverse Events (Safety)

    Assess the frequency of adverse events during the holding intervention including unintentional rewarming of the infant, dislodged infant catheters (umbilical arterial/venous lines, urinary catheter, iv) or infant intolerance of holding due to vital sign instability.

    3 days

Secondary Outcomes (13)

  • Qualitative Experience of Mothers: Before I Could Hold my Baby, I Would Describe Our Ability to Bond as:

    3 days

  • Qualitative Experience of Mothers: After Holding my Baby, I Feel Our Bond is:

    3 days

  • Qualitative Experience of Mothers: Before Holding my Baby, my Stress Level Was:

    3 days

  • Qualitative Experience of Mothers: After Holding my Baby, I Feel:

    3 days

  • Qualitative Experience of Mothers: I am Glad I Had the Opportunity to Hold my Baby During Treatment With Hypothermia

    3 days

  • +8 more secondary outcomes

Study Arms (1)

Holding Group

EXPERIMENTAL

After meeting inclusion criteria and consenting to participation, mothers of infants who have completed at least 24 hours of therapeutic hypothermia treatment will be allowed to hold their infant who will remain on the cooling blanket for a 30-minute period with the use of a thermal barrier. Vital signs will be measured before holding begins, during holding and following completion of holding. Temperature will be recorded every two minutes during holding. Afterwards, a Likert scale questionnaire to assess the mother's and nurse's reactions will be administered.

Other: Holding during cooling

Interventions

An initial set of vital sings will be recorded before the infant is removed from the isolette. The mother will sit in a reclining chair next to the isolette and place a thermal barrier over her chest and abdomen. The infant will be transferred to the mother by placing the hands under the cooling blanket so as to move the infant and cooling blanket together as one unit. The mother will be allowed to hold for thirty minutes provided that the infant's temperature does not increase by greater than one degree centigrade and the oxygen saturation does not drop below 90%. After thirty minutes, the infant will be returned to the isolette.

Holding Group

Eligibility Criteria

Age24 Hours - 3 Days
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Infant must have a gestational age of greater than or equal to 35 weeks
  • Infant must be undergoing treatment with therapeutic hypothermia
  • Infant must be without seizures in the first 24 hours of treatment based on EEG
  • Infant must be clinically stable on bubble CPAP, nasal cannula, or no respiratory support.
  • Informed consent must be signed by the mother at Maine Medical Center

You may not qualify if:

  • Infant is intubated
  • Infant is being treated with inhaled nitric oxide
  • Presence of Persistent Pulmonary Hypertension of the Newborn
  • Presence of seizure on EEG
  • Use of vasopressors or paralytic agents
  • Presence of chest tubes, wound vacuums, or drains
  • Neonatal abstinence syndrome

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Maine Medical Center

Portland, Maine, 04102, United States

Location

Related Publications (1)

  • Craig A, Deerwester K, Fox L, Jacobs J, Evans S. Maternal holding during therapeutic hypothermia for infants with neonatal encephalopathy is feasible. Acta Paediatr. 2019 Sep;108(9):1597-1602. doi: 10.1111/apa.14743. Epub 2019 Mar 5.

MeSH Terms

Conditions

Hypoxia-Ischemia, Brain

Condition Hierarchy (Ancestors)

Brain IschemiaCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesHypoxia, BrainVascular DiseasesCardiovascular DiseasesHypoxiaSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Dr. Alexa Craig
Organization
Maine Medical Center

Study Officials

  • Alexa Craig, MD, MSc

    MaineHealth

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assistant Professor of Pediatrics

Study Record Dates

First Submitted

March 6, 2017

First Posted

March 14, 2017

Study Start

March 20, 2017

Primary Completion

September 23, 2017

Study Completion

September 23, 2017

Last Updated

September 4, 2025

Results First Posted

January 26, 2022

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations